FindMyKOL
Clinical trialNCT04941430TerminatedInterventional

7T MRI Scan for the Early Detection of Melanoma Brain Metastases

NCT04941430 is an interventional trial sponsored by University of Southern California. As of 21 Nov 2026, it was terminated. It studies Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Malignant Neoplasm in the Brain and 2 more conditions. The registry lists an enrollment of 2 participants at 1 site in 1 country. The registry lists a start date of 25 Jun 2021 and a primary completion date of 10 Jan 2025.

SponsorUniversity of Southern California →Enrollment2Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Malignant Neoplasm in the BrainMetastatic MelanomaPathologic Stage IV Cutaneous Melanoma AJCC v8
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT04941430
FieldValue
Registry IDNCT04941430
StatusTerminated
Study typeInterventional trial
Lead sponsorUniversity of Southern California
Enrollment2
Registered sites1
Countries1
ConditionsClinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Malignant Neoplasm in the Brain, Metastatic Melanoma and Pathologic Stage IV Cutaneous Melanoma AJCC v8
Start25 Jun 2021
Primary completion10 Jan 2025
Study completion10 Jan 2025
Last update posted12 Aug 2025

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This clinical trial studies the use of 7-Tesla (7T) magnetic resonance imaging (MRI) in detecting melanoma that has spread to the brain (melanoma brain metastases). The standard MRI brain imaging is done on 3T or similar MRI machine, but the 7T MRI machine has a larger magnet which has been shown to have superior resolution of the brain and of non-cancerous brain lesions. Diagnostic procedures such as 7T MRI may help find and diagnose melanoma brain metastases earlier than standard 3T MRI.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

California, United States1 site
  • Usc / Norris Comprehensive Cancer Center

    Los Angeles

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichiganMINew YorkNYMassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhioOHPennsylvaniaPANew JerseyNJConnecticutCTCalifornia: 1 siteCA1NevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexasTXFloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT04941430

Each answer restates registry values shown on this page.

What is NCT04941430?

NCT04941430 is an interventional trial sponsored by University of Southern California. It studies Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Malignant Neoplasm in the Brain and 2 more conditions.

Who leads NCT04941430?

The registry names Lindsay Hwang (principal investigator, University of Southern California) as the overall official.

Where does NCT04941430 run?

The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.

When did NCT04941430 end?

The registry lists a primary completion date of 10 Jan 2025 and a study completion date of 10 Jan 2025. The sponsor last updated the record on 12 Aug 2025.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.